Recursion Pharmaceuticals

Recursion Pharmaceuticals is a clinical-stage biotechnology company that uses a hybrid lab-to-cloud platform to identify treatments for diseases that can be modeled at the cellular level. Recursion has developed a unique approach to identifying and designing new therapies using artificial intelligence (AI) models. The company’s technology is now used to build a map of human cellular biology, which can help increase the pace of discovering new treatments.